VNRX

Companies
Nyse American
VolitionRx Limited
Health Care
Price Chart
Overview

About VNRX

volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.

Market Cap
$56.3M
Volume
133.8K
Avg. Volume
94.2K
P/E Ratio
-2.875
Dividend Yield
0.00%
Employees
84.0

Company Information

Exchange
Nyse American
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
1.17
Moderate Correlation
Volatility
High (0.94)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VNRX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VNRX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$56.3M
Volume133.8K
P/E Ratio-2.88
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 1, 2025

PortfolioPilot Analysis

Get AI-powered insights on how VNRX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025